Loren Data's SAM Daily™

fbodaily.com
Home Today's SAM Search Archives Numbered Notes CBD Archives Subscribe
FBO DAILY - FEDBIZOPPS ISSUE OF MARCH 02, 2014 FBO #4481
SOURCES SOUGHT

65 -- Classical Swine Fever (CSF) Virus Vaccine, DIVA

Notice Date
2/28/2014
 
Notice Type
Sources Sought
 
NAICS
325414 — Biological Product (except Diagnostic) Manufacturing
 
Contracting Office
Department of Agriculture, Animal and Plant Health Inspection Service, Administrative Services Division/Contracting, 100 North 6TH Street, Butler Square 5TH Floor, Minneapolis, Minnesota, 55403
 
ZIP Code
55403
 
Solicitation Number
CSFVIRUSVACCINE
 
Archive Date
3/31/2014
 
Point of Contact
Larry D Nelson, Phone: 612-336-3225
 
E-Mail Address
Larry.D.Nelson@aphis.usda.gov
(Larry.D.Nelson@aphis.usda.gov)
 
Small Business Set-Aside
N/A
 
Description
BACKGROUND: The United States Department of Agriculture (USDA), Animal and Plant Health Inspection Service (APHIS), Veterinary Services (VS), National Veterinary Stockpile (NVS) intends to obtain price, delivery, other market information, or capabilities for planning purposes for obtaining Classical Swine Fever Virus Vaccine (s), DIVA. Responses to this notice are not offers and cannot be accepted by the Government to form a binding contract. The goal is to develop sources of CSF vaccines for possible order by the USDA in the event of an outbreak of CSF in the United States. REQUIREMENT: The vaccine(s) must be (1) in on-going production, distribution, and use in one or more jurisdictions or countries in the world; and (2) suitable for use in swine. PURPOSE AND OBJECTIVES: The primary objective of issuing the RFI is to seek information and comments from companies that own or have the right/ability to license/permit CSF vaccines. A. Describe your company Classical Swine Fever Virus Vaccine(s) DIVA that is/are currently in production and distribution. B. Identify marketing authorizations or approvals for your company's CSF vaccine(s). C. Provide a brief description of the manufacturing facilities and process. D. Provide a brief summary of purity, safety, potency, proof of licensor, and efficacy data. E. Provide a brief summary of the companion diagnostic test(s) that makes your CSF vaccine compatible with a DIVA strategy. F. Provide the cost for per dose. SUBMISSION INSTRUCTIONS: All written responses must be received within 21 days of issuance of this RFI. Submissions should: (1) use Microsoft Word or Adobe Portable Document Format (PDF); (2) be sent to the point of contact listed in this notice; (3) be minimum 11 font on 8.5 X 11 paper; (4) be complete, sufficiently detailed, and organized in a manner that tracks to the information requested in this RFI; (5) include a single company point of contact with name, title, address, telephone and fax numbers, and e-mail address(es); and (6) not exceed 10 single sided pages in total (not including cover page and cover letter). Other media types (i.e. CD, printed technical information) that meet the submission criteria above will be accepted and should be sent. Material that is advertisement only in nature is not desired. Any questions or inquiries must be mailed, e-mailed or faxed to the Contracting Office, to the attention of the point of contact listed in this notice.
 
Web Link
FBO.gov Permalink
(https://www.fbo.gov/spg/USDA/APHIS/Contracting/CSFVIRUSVACCINE/listing.html)
 
Record
SN03299809-W 20140302/140228234702-17adbd802f81758e5a41c86503693deb (fbodaily.com)
 
Source
FedBizOpps Link to This Notice
(may not be valid after Archive Date)

FSG Index  |  This Issue's Index  |  Today's FBO Daily Index Page |
ECGrid: EDI VAN Interconnect ECGridOS: EDI Web Services Interconnect API Government Data Publications CBDDisk Subscribers
 Privacy Policy  Jenny in Wanderland!  © 1994-2024, Loren Data Corp.